84 related articles for article (PubMed ID: 31053566)
21. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.
Benard VB; Howe W; Saraiya M; Helsel W; Lawson HW
J Low Genit Tract Dis; 2008 Oct; 12(4):300-6. PubMed ID: 18820545
[TBL] [Abstract][Full Text] [Related]
22. Abnormal Pap smear follow-up in a high-risk population.
Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
[TBL] [Abstract][Full Text] [Related]
23. [ASC-US Pap Smear follow-up in a French department in 2077].
Giuria C; Guiheneuc E; Coimet F; Caillez E; Baron C
Sante Publique; 2015; 27(5):659-67. PubMed ID: 26752032
[TBL] [Abstract][Full Text] [Related]
24. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
[TBL] [Abstract][Full Text] [Related]
25. Limitations in Correspondence Programs for Cervical Cancer Screening: Who Are the Women We Are Missing?
Clark M; Lee A; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1410-1415. PubMed ID: 30803876
[TBL] [Abstract][Full Text] [Related]
26. Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.
Wen KY; Dayaratna S; Slamon R; Granda-Cameron C; Tagai EK; Kohler RE; Hudson SV; Miller SM
Transl Behav Med; 2024 Jan; 14(1):1-12. PubMed ID: 38014626
[TBL] [Abstract][Full Text] [Related]
27. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy.
Miller SM; Siejak KK; Schroeder CM; Lerman C; Hernandez E; Helm CW
J Natl Cancer Inst; 1997 May; 89(10):703-8. PubMed ID: 9168185
[TBL] [Abstract][Full Text] [Related]
28. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
Martingano D; Renson A; Martingano AJ; Martingano FX
J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
[TBL] [Abstract][Full Text] [Related]
29. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.
Nayir T; Okyay RA; Nazlican E; Yesilyurt H; Akbaba M; Ilhan B; Kemik A
Asian Pac J Cancer Prev; 2015; 16(16):6909-12. PubMed ID: 26514466
[TBL] [Abstract][Full Text] [Related]
30. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
Whop LJ; Baade P; Garvey G; Cunningham J; Brotherton JM; Lokuge K; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig DM; Moore SP; Condon JR
PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
[TBL] [Abstract][Full Text] [Related]
31. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of a Decade of Routine Cervical Screening in a Canadian Adolescent Obstetrics Clinic.
Korkidakis A; Bryson P; Jamieson MA
J Obstet Gynaecol Can; 2016 Jan; 38(1):51-5. PubMed ID: 26872756
[TBL] [Abstract][Full Text] [Related]
33. Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.
Kyrgiou M; Kalliala I; Mitra A; Ng KY; Raglan O; Fotopoulou C; Martin-Hirsch P; Paraskevaidis E; Arbyn M
Int J Cancer; 2017 Jan; 140(1):216-223. PubMed ID: 27603593
[TBL] [Abstract][Full Text] [Related]
34. Consequences of current patterns of Pap smear and colposcopy use.
Kavanagh AM; Santow G; Mitchell H
J Med Screen; 1996; 3(1):29-34. PubMed ID: 8861048
[TBL] [Abstract][Full Text] [Related]
35. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
[TBL] [Abstract][Full Text] [Related]
36. Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas.
Carrillo T; Montealegre JR; Bracamontes CG; Scheurer ME; Follen M; Mulla ZD
BMC Womens Health; 2021 Jan; 21(1):11. PubMed ID: 33407351
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with timely colposcopy following an abnormal cervical cancer test result.
Feldman S; Lykken JM; Haas JS; Werner CL; Kobrin SC; Tiro JA; Chubak J; Kamineni A
Prev Med; 2022 Nov; 164():107307. PubMed ID: 36270434
[TBL] [Abstract][Full Text] [Related]
38. Video colposcopy improves adherence to follow-up compared to regular colposcopy: a randomized trial.
Takacs P; Chakhtoura N; De Santis T
Arch Gynecol Obstet; 2004 Nov; 270(3):182-4. PubMed ID: 15205983
[TBL] [Abstract][Full Text] [Related]
39. The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index.
Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
Cancer Prev Res (Phila); 2020 Mar; 13(3):299-308. PubMed ID: 31836602
[TBL] [Abstract][Full Text] [Related]
40. Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy.
Percac-Lima S; Aldrich LS; Gamba GB; Bearse AM; Atlas SJ
J Gen Intern Med; 2010 Nov; 25(11):1198-204. PubMed ID: 20652647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
